title: Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications.
authors.affiliation: From the University of Texas Southwestern Medical Center, Department of Obstetrics and Gynecology, Parkland Health and Hospital System, Dallas, Texas.
authors.forename: Laura G
authors.initials: LG
authors.lastname: Greer
authors.forename: Jeanne S
authors.initials: JS
authors.lastname: Sheffield
authors.forename: Vanessa L
authors.initials: VL
authors.lastname: Rogers
authors.forename: Scott W
authors.initials: SW
authors.lastname: Roberts
authors.forename: Donald D
authors.initials: DD
authors.lastname: McIntire
authors.forename: George D
authors.initials: GD
authors.lastname: Wendel
mesh_terms: D000547:Amantadine / Q000009:adverse effects / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D020345:Enterocolitis, Necrotizing / Q000209:etiology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007251:Influenza, Human / Q000188:drug therapy* / Q000517:prevention & control; D053139:Oseltamivir / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000517:prevention & control; D011256:Pregnancy Outcome; D012299:Rimantadine / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D012299:Rimantadine; D053139:Oseltamivir; D000547:Amantadine